March 2, 2017 / 9:29 PM / 6 months ago

BRIEF-Syndax pharmaceuticals reports Q4 loss per share $0.59

March 2 (Reuters) - Syndax Pharmaceuticals Inc:

* Syndax Pharmaceuticals reports fourth quarter and year-end 2016 financial results and provides clinical and business update

* Q4 loss per share $0.59

* Q4 earnings per share view $-0.70 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below